ARL6IP1P1

Across TCGA pan-cancer cohorts, ARL6IP1P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated ARL6IP1P1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ARL6IP1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARL6IP1P1 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

CESC, READ, and KIRC are the cancer types where ARL6IP1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	0.239	0.764	.007	78	view →
READ	DFS	Tertile	II,III,IV	0.366	0.816	<.001	45	view →
KIRC	DFS	Tertile	IV	0.261	0.646	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	30	view →
BLCA	DFS	Tertile	All	0.355	0.632	.018	24	view →
KIRP	OS	Tertile	All	0.193	0.714	.004	21	view →
LUAD	DFS	Tertile	III,IV	1.000	0.289	.042	18	view →
LGG	OS	Tertile	All	0.656	0.912	.015	9	view →
TGCT	DFS	Tertile	All	0.169	0.682	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ARL6IP1P1–CESC (OS)

Open the CESC breakdown →